Functional Precision Medicine Method Aids Treatment Decision-Making in R/R Pediatric Cancers
A unique approach combining genomic and sensitivity testing with machine learning was feasible for guiding treatment selection in pediatric cancers.
A unique approach combining genomic and sensitivity testing with machine learning was feasible for guiding treatment selection in pediatric cancers.
This cohort study examines the role of comprehensive bridging radiotherapy in the setting of chimeric antigen receptor T-cell therapy for non-Hodgkin lymphoma.
Knowing about the most common cancers that affect women and how to lower your risk or find them early may help save your life or…
The FDA has granted breakthrough therapy designation to petosemtamab in recurrent or metastatic head and neck squamous cell carcinoma.
In two studies reported in The New England Journal of Medicine, investigators found that a cell-free DNA blood-based test (ECLIPSE study) and a next-generation multitarget…
Knowing what symptoms to look for can help your doctor find cancer early when it’s most treatable.
Repotrectinib has been approved by China’s National Medical Products Administration for the treatment of patients with ROS1-positive NSCLC.
Get the facts about basal cell carcinoma (BCC), the most common form of skin cancer, along with answers to your questions and images.
AbstractBackground. RECIST criteria for progressive disease, partial response, and complete response, reflecting +20%, −30%, and −100% tumor size changes,
This Viewpoint discusses laws mandating insurance coverage of biomarker testing to broaden access to care for patients with cancer.
The OncoAlert Newsletter is now out for June 23-29, 2023